Operating under the FDA's 503B pathway, the Apex facility will prioritize the production of generic shortage-listed ...
Rosti Group constructs sterile production facilities at Wisconsin and Utah plants to serve medical device manufacturing ...
Simtra positioned to become the first CDMO to offer commercial-scale drug product manufacturing of antibody-drug conjugates (ADCs) in the United States, enabling customers to complete the entire ...
Apiject Holdings Inc. has signed a lease for a 30,000-square-foot pharmaceutical manufacturing facility in Apex, North ...
Swiss medtech company Ypsomed has announced plans to establish its first U.S. manufacturing facility in Holly Springs, North Carolina, with production scheduled to begin by the end of 2027. The ...
In today’s competitive and environmentally-conscious manufacturing landscape, companies are increasingly seeking innovative solutions that improve efficiency, reduce waste, and enhance sustainability.
Subcutaneous implants are injectable drug delivery systems effective for treatments lasting weeks to years. These implants ensure the active pharmaceutical ingredient (API) is released precisely where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results